Cornercap Investment Counsel’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-2,679
Closed -$215K – 502
2024
Q3
$215K Sell
2,679
-3,306
-55% -$267K 0.06% 472
2024
Q2
$495K Sell
5,985
-9,487
-61% -$835K 0.08% 454
2024
Q1
$1.32M Buy
15,472
+1,327
+9% +$104K 0.2% 142
2023
Q4
$1.21M Hold
14,145
– – 0.2% 154
2023
Q3
$1.27M Sell
14,145
-97
-0.7% -$8.66K 0.23% 115
2023
Q2
$1.21M Sell
14,242
-85
-0.6% -$7.19K 0.21% 133
2023
Q1
$1.19M Buy
14,327
+211
+1% +$17.1K 0.21% 128
2022
Q4
$1.11M Buy
14,116
+65
+0.5% +$5.22K 0.19% 164
2022
Q3
$1.04M Sell
14,051
-2,914
-17% -$209K 0.2% 154
2022
Q2
$1.11M Buy
+16,965
New +$1M 0.19% 153
2021
Q3
– Sell
-17,804
Closed -$1.19M – 569
2021
Q2
$1.19M Buy
+17,804
New +$1.26M 0.13% 258
2020
Q3
– Sell
-9,964
Closed -$892K – 507
2020
Q2
$892K Buy
+9,964
New +$1.01M 0.14% 238
2017
Q4
– Sell
-15,715
Closed -$705K – 416
2017
Q3
$705K Buy
+15,715
New +$653K 0.1% 311
2015
Q4
– Sell
-13,615
Closed -$440K – 364
2015
Q3
$440K Buy
+13,615
New +$512K 0.09% 207

Other funds holding HAE

Cornercap Investment Counsel's HAE Position: Q4 2024 in Review

Cornercap Investment Counsel sold out of Haemonetics (HAE) in Q4 2024, closing a stake of 2,679 shares — an estimated $215K sold.

Cornercap Investment Counsel first reported a position in HAE in Q3 2015 and held it in 14 quarters. The position peaked at $1.32M in Q1 2024. 309 funds tracked by Wall St. Rank hold HAE as of Q4 2024.

  • Cornercap Investment Counsel reported no remaining Haemonetics position as of Q4 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 2,679 Haemonetics shares in Q4 2024, an estimated $215K.
  • Cornercap Investment Counsel first reported a position in Haemonetics in Q3 2015 and held it in 14 quarters.
  • Cornercap Investment Counsel's Haemonetics position peaked at $1.32M in Q1 2024.
  • 309 funds tracked by Wall St. Rank held Haemonetics as of Q4 2024.

Based on Cornercap Investment Counsel's 13F filing for Q4 2024, filed 12 Feb 2025.